Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008-2022) [0.03%]
利比里亚药品不良反应报告的趋势和模式：VigiFlow 数据的回顾性分析（2008-2022）
Isatu Jalloh,Onome Thomas Abiri,Peter Bai James et al.
Isatu Jalloh et al.
Purpose: Adverse drug reactions (ADRs) present significant obstacles for healthcare systems, impacting both patient safety and the effectiveness of treatments. Despite this, there is a scarcity of research on ADR reports ...
Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study [0.03%]
基于英国真实世界数据的罗非昔布心血管不良事件早期识别：病例对照及病例交叉研究
Donya Moslemzadeh,Patrick C Souverein,Svetlana V Belitser et al.
Donya Moslemzadeh et al.
Background: Traditional pharmacovigilance systems have limitations in detecting common adverse drug reactions. We investigated whether real-world data (RWD) could have detected rofecoxib's cardiovascular adverse effects e...
Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study [0.03%]
短期使用复方新诺明治疗单纯性膀胱炎的的安全性：全国范围回顾性队列研究
Jumpei Taniguchi,Shotaro Aso,Hideo Yasunaga
Jumpei Taniguchi
Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is associated with hypersensitivity and other adverse reactions. East Asian-specific genetic susceptibility may increase severe adverse events, limiting the therapeutic ...
Assessment of Off-Label Psychotropic Drug Use in Children and Adolescents: A Multi-Center Cross-Sectional Study in China [0.03%]
我国儿童和青少年心理行为药物临床应用调查横断面研究
Yue-Peng Teng,Cai-Dong Li,Wen-Juan Lei et al.
Yue-Peng Teng et al.
Purpose: This study aimed to assess the use of psychotropic drugs in children and adolescents and their off-label use in clinical settings across multiple hospitals in China, as well as to further analyze the influencing ...
Multicenter Study
Pharmacoepidemiology and drug safety. 2026 Mar;35(3):e70340. DOI:10.1002/pds.70340 2026
Characteristics of United States Food and Drug Administration Drug Recalls Involving Opioid Medications, 2002-2025 [0.03%]
2002年至2025年美国食品药品管理局公布的含阿片类药物的药品召回情况分析
Julio C Nunes,Gabriel P A Costa,Joao P De Aquino
Julio C Nunes
Purpose: To characterize the frequency, causes, and severity of opioid medication recalls using United States Food and Drug Administration (FDA) Enforcement Reports. ...
Performance of the Self-Controlled Case Series for Drug Safety Signal Detection: A Multi-Database Study [0.03%]
自我控制病例系列在药物安全性信号检测中表现如何？多数据库研究
Astrid Coste,Angel Y S Wong,Francois Haguinet et al.
Astrid Coste et al.
Background: Differences in performance of the Self-Controlled Case Series (SCCS) for signal detection have been reported across different databases. However, there has been limited comparative analysis of performance and ...
Comparative Study
Pharmacoepidemiology and drug safety. 2026 Feb;35(2):e70298. DOI:10.1002/pds.70298 2026
Evaluating Data Quality by Proxy: Can We Evaluate All Dimensions of the European Medicines Agency Data Quality Framework for Registry-Based Post-Authorization Safety Studies? [0.03%]
代理评估数据质量：我们能否评估基于登记的上市后安全性研究的所有维度的欧洲药品管理局数据质量框架？
Pamela Dobay,Meritxell Sabidó
Pamela Dobay
Purpose: An increasing number of studies based on secondary data use, including registry-based studies, have been initiated to address post-authorization regulatory commitments. We map differences across tools used in dat...
Effectiveness of Indapamide Prolonged-Release and Perindopril Versus Perindopril Monotherapy for Treated Uncontrolled Hypertension: A Target Trial Emulation [0.03%]
评估吲达帕胺缓释剂联合培哚普利与单纯使用培哚普利治疗难治性高血压的疗效：靶向试验模拟研究
Céline Darricarrere,Virginie Simon,Manel Pladevall-Vila et al.
Céline Darricarrere et al.
Objective: To assess the effectiveness of indapamide prolonged release and perindopril in combination using blood pressure (BP) records collected in routine practice. ...
Observational Study
Pharmacoepidemiology and drug safety. 2026 Feb;35(2):e70295. DOI:10.1002/pds.70295 2026
Correction to "Demystifying Clone-Censor-Weighting to Studying Treatment Initiation Windows: An Example Using Publicly Available Synthetic Medicare Claims Data" [0.03%]
对“揭开克隆-审查-加权研究治疗启动窗口的神秘面纱：使用公开可用的合成Medicare索赔数据进行示例”的修正
Published Erratum
Pharmacoepidemiology and drug safety. 2026 Feb;35(2):e70334. DOI:10.1002/pds.70334 2026
Incidence and Clinical Significance of Drug-Induced Antibodies and Hemolytic Anemia Associated With Beta-Lactam Antibiotics: A Prospective Cohort Study [0.03%]
一项前瞻性队列研究：药物诱导性抗体和β-内酰胺类抗生素相关溶血性贫血的发病率及临床意义
Li Wang,Lixin Wang,Zengzhen Wei et al.
Li Wang et al.
Background: Drug-induced immune hemolytic anemia (DIIHA), a rare complication of beta-lactams, lacks population-level data on subclinical antibody prevalence. ...